搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Investor's Business Daily on MSN
1 小时
Legend Biotech Rises After J&J-Tied Cancer Drug Cuts Risk Of Death By 45%
Legend Biotech jumped Monday after the company said its J&J-tied multiple myeloma drug, Cavykti, cut the risk of death.
labiotech
13 天
Estonia: Seven biotech companies to reckon with
Explore Estonia’s biotech scene with 7 pioneering companies across Tallinn, Tartu, and beyond, fueled by top science parks ...
pharmaphorum
2 小时
Chiesi Biotech Center of Excellence opens to strengthen R&D in Italy
Chiesi’s strategy aligns with EU priorities on innovation, security, and private R&D investment: the decision to establish a ...
4 天
on MSN
A surfer without a degree is worth $16 billion after his biotech company's stock soared ...
Bob Duggan, 80, has gone from baking cookies to building robots, investing in biotech companies, and ranking among the ...
8 小时
Genenta Science S.p.A. (GNTA): Early Investment Opportunity in Innovative Biotech
We recently published a list of 10 Best Italian Stocks To Buy Now. In this article, we are going to take a look at where ...
8 天
The Best Biotech Stock to Invest $1,000 in Right Now
The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group ...
5 天
Biotech company Eradivir closes $10.25M Series A funding round to complete Phase 2a study ...
Eradivir $10.25M Series A funding round Two Eradivir employees conduct research on the company’s EV25 influenza therapeutic.
Crain's Chicago Business
3 天
Arch Venture Partners closes $3B fund to invest in next-gen biotech startups
Chicago-based venture-capital firm Arch Venture Partners has closed a new $3 billion fund to invest in early-stage ...
STAT
4 天
ARCH Venture Partners raises $3 billion for a new biotech fund
ARCH Venture Partners has raised $3 billion for a new fund — one of the largest in the biotech industry, and one the VC firm ...
4 天
Trinity Biotech股价触及52周新低,跌至1.15美元,面临诸多挑战
在充满重大挑战的一年里,Trinity Biotech股价已触及新的52周低点,交易价格为1.15美元。这家以医疗检测产品组合闻名的诊断公司,过去一年股价大幅下跌,跌幅高达66.01%。由于公司正在应对行业范围内的压力和竞争动态,投资者对此持谨慎态度,这显然影响了其市场估值。目前的价格水平对Trinity Biotech来说是一个关键时刻,利益相关者密切关注公司为应对严峻的经济形势而采取的战略举措 ...
6 小时
Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create ...
(NASDAQ:THAR) ("Tharimmune"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, and Intract Pharma Ltd. ("Intract"), a ...
9 天
NKGen Biotech发行股票以进行债务转换
生物技术公司NKGen Biotech, Inc. (NASDAQ:NKGN)周一宣布,根据债务转换协议,该公司已发行约162,000股普通股。 这些股票以每股0.60美元的价格发行给公司可转换票据的两位持有人,这一价格是在转换前10个交易日内任何交易日普通股最低成交量加权平均价格的80%。 根据可转换票据的条款,对转换价格进行了调整,这被视为公司票据和认股权证相关条款中规定的稀释性发行。因此,截 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈